A Multicenter Open-Label Study to Assess the Pharmacokinetics Safety and Efficacy of Certolizumab Pegol in Children and Adolescents with Moderately to Severely Active Polyarticular-Course Juvenile Idiopathic Arthritis
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this clinical research study is to assess the pharmacokinetics (blood concentration of the study medication during and after treatment) and the safety of CZP (Cimzia) in children and adolescents with JIA.
Description
The purpose of this clinical research study is to assess the pharmacokinetics (blood concentration of the study medication during and after treatment) and the safety of CZP (Cimzia) in children and adolescents with JIA.
Details
| Condition | Juvenile Idiopathic Arthritis |
|---|---|
| Age | 2years - 17years |
| Clinical Study Identifier | TX2444 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.